Skip to main content
OpenTrials
Completed

NCT Number: NCT04818294

Clinical Trial to Monitor the Efficacy of the Elosan Treatment by Applying Electrostatic

The Treatment Cabin 'Elosan cabin' is a closed, electrically insulated cabin for the short-term application of a high electrostatic voltage to the body of patients with chronic pain.

Patients assigned will have 8 sessions in the treatment cabin, with an interval of 6 days between sessions. The existing therapies and painkillers will be continued at the discretion of the doctor.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Chronic Pain Neurologic Manifestations Pain Pathological Conditions, Signs and Symptoms Signs and Symptoms

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Centro Ortho-Bio-Med, Roveredo, CH, Switzerland

Loading trial locations.

About this study

Included in the study can be all persons suffering from chronic pain as it is often the case with rheumatic disease or traumata. The electric charge is created by a generator which can produce a high electrostatic field. The electrical voltage is delivered to the hands via a metal handle and is spread over the entire body surface. After the short treatment, the patient is completely discharged and earthed again.

Over 100 patients in eight pain centers are to be included into this trial in order to show a statistically significant reduction of pain.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Informed Consent
  • adults, age ≥ 18 years, male or female patients
  • History of pain ≥ 3 months
  • Suffering from chronic pain
  • Intensity of pain rated ≥ 50 mm on VAS pain

Exclusion criteria

  • Patients with an electrical or electronic implant.
  • Women who are pregnant, breastfeeding or planning to become pregnant
  • Patients who have already been treated with the cabin within the last 4 weeks.
  • Patients who are currently participating in other studies or who have participated in other studies in the last 30 days
  • Patients who have indicated their intention or who are suspected of intending to discontinue or discontinue therapy before the end of the study

Treatment and study plan

Pain treatment by electrostatic charge to the whole body

Device

Study Type is Observational as participants in the study receive therapeutic interventions in the therapy cabin as part of routine medical care and a researcher studies the effect of the intervention.

The study includes all persons who are already receiving therapy in the mentioned facilities, no external, specifically selected persons, but existing patients suffering from chronic pain who meet the specified conditions.

The therapy aims to alleviate chronic pain by applying an electrostatic charge of 50'000 Volt to the whole body in the special, electrically insulated cabin. The treatment is done upon the instructions of a physician. It is done with the patient standing up in the treatment cabin. The person is charged and discharged several times over the course of 2x 4 minutes. The charge can be felt on the skin and it can be seen through bristling of the hairs on the body. This treatment is repeated once a week.

Primary outcomes

  1. Change of Pain Intensity is being assessed by Visual Analogue Scale (VAS)

    Time frame: 8-9 weeks

    Change of Pain Intensity is being assessed on a horizontal 100 mm VAS (Visual Analogue Scale) pain scale. The total range of this scale is 100 mm. Minimum score is 0 mm, Maximum score is 100 mm. The higher values represent a higher intensity of pain. The values at baseline will be compared to the values at Visit 8 and the mean of the differences will be compared between the 2 treatment arms.

Secondary outcomes

  1. Composite outcome physical health (PCS) and mental health (MCS) to determine the quality of life assessed by the SF-12 Questionnaire

    Time frame: 8-9 weeks

    Patients fill out a 12 question survey at the first and the last visit, which is then scored by a researcher.

    The 12-Item Short Form Survey (SF-12) is designed as a general measure of health. It is a quality of Well-Being Score in comparison to US general population. Composite outcome physical health (PCS) and mental health (MCS) to determine the quality of life assessed by SF-12 Questionnaire compared to the United States average (avg=50)

    The change in quality of life (as reported by SF 12 questionnaires) from baseline to end of treatment (Day 28) will be compared between the treatment groups. The impact of the changes in summary scores (NBS: Norm-Based-Scoring) of physical health (PCS) and mental health (MCS) will be assessed by a General Linear Model (GLM) using the treatment as fixed factors and the baseline PCS and MCS as covariates, respectively.

  2. Pain medication / therapy and any changes thereof shall be recorded during the study.

    Time frame: 8-9 weeks

    To determine the effects on standard treatment, medication and other, different therapies, a special questionnaire is collected per patient.

    This lists the dose of all medications and therapies as follows:

    • until the start of the study
    • at each of the 8 visits
    • at the end of the study

    Medication will vary from patient to patient. Therefore, the dose of comparable medications/therapies, mainly pain medications, will be assessed.

    The pain medication taken at baseline will be compared to the amount of pain medication taken at the end of treatment. Changes in pain medication will be qualified by the investigators as either being clinically relevant or not.

Other outcomes

  1. Improving the quality of sleep

    Time frame: 8-9 weeks

    The quality of sleep is recorded on the questionnaire at each visit

Sponsors and collaborators

Lead sponsor

Elosan AG

Industry

Registry information

Official study title

Prospective, Multi-center, Clinical Trial (Phase IV Study) to Monitor the Efficacy of Treatment by Applying a High Electrostatic Charge to Patients With Chronic Pain, in the Practice of Clinical or Out-patient Pain Treatment Facilities.

Important dates

Study start
2021
Primary completion
2022
Study completion
2022
First posted
Mar 26, 2021
Registry last updated
Jan 26, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.